Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sialyltransferase
93%
Multiple Myeloma
71%
Interferon-α (IFN-α)
46%
Polycythemia Vera
46%
Sialic Acid
44%
Cyclophosphamide
39%
Chemotherapy
36%
Incubation
36%
Testicle
36%
RhEPO
34%
Tissue Plasminogen Activator (t-PA)
34%
Prednisone
32%
Non-Hodgkin Lymphoma
31%
Lymphocytes
29%
Myeloma
29%
Elderly Patients
28%
Lymphoma Patients
27%
Platelet Aggregation
27%
Doxorubicin
25%
Diffuse Large B-cell Lymphoma (DLBCL)
25%
Human Sperm
25%
Myelofibrosis
25%
R-CHOP
23%
Myelodysplastic Syndrome
23%
Bone Marrow Cells
23%
Chronic Myeloid Leukemia
23%
Epididymis
23%
Myeloma Cells
23%
Peripheral White Blood Cells
23%
AF10
23%
Phosphatidylinositol
23%
Autoanalyzer
23%
Leukemia
23%
PIM2
23%
Lenalidomide Maintenance
23%
Procarbazine
23%
Human Lung Fibroblasts
23%
Hitachi
23%
Liposomes
23%
Peripheral Blood Mononuclear Cells
19%
Myeloproliferative Neoplasms
19%
Apoptosis
18%
Placebo
18%
Acrosome Reaction
18%
Rituximab
18%
Progression-free Survival
17%
Multiple Myeloma Patients
17%
Acute Leukemia
17%
Plasma Cells
17%
Globulin
17%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Myeloma
65%
Cyclophosphamide
58%
Sialyltransferase
46%
Interferon
46%
Dexamethasone
46%
Lenalidomide
37%
Chemotherapy Regimens
36%
Recombinant Erythropoietin
34%
Vincristine
34%
Rituximab
34%
Tissue Plasminogen Activator
34%
Doxorubicin
27%
Prednisone
27%
Diseases
23%
Melphalan
23%
Alpha2b Interferon
23%
Procarbazine
23%
Diffuse Large B Cell Lymphoma
23%
Phosphatidylinositol
23%
Myelodysplastic Syndrome
23%
Liposome
23%
Globulin
23%
Rat
23%
Polycythemia vera
23%
Adverse Event
22%
Progression Free Survival
21%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
19%
Erythropoietin
17%
Anemia
16%
Placebo
16%
Acute Leukemia
13%
Thrombocytopenia
13%
Remission
12%
Randomized Controlled Trial
12%
Calcium Ion
11%
Methazolamide
11%
Clomifene Citrate
11%
Pharynx Hemorrhage
11%
Liver Cell Carcinoma
11%
Tumor Lysis Syndrome
11%
Lymphatic Leukemia
11%
Primary Central Nervous System Lymphoma
11%
Dipyridamole
11%
Fedratinib
11%
Belantamab Mafodotin
11%
Thrombotic Thrombocytopenic Purpura
11%
Diclofenac
11%
Methotrexate
11%
Androgen
11%
Medicine and Dentistry
Multiple Myeloma
58%
Thrombocyte Aggregation
48%
Lymphocyte
42%
Polycythemia vera
38%
Thrombocyte Function
34%
Hodgkin's Lymphoma
29%
Chronic Lymphocytic Leukemia
27%
Myelodysplastic Syndrome
27%
B-Cell Chronic Lymphocytic Leukemia
26%
Non-Hodgkin Lymphoma
26%
Myelofibrosis
25%
Adenosine Diphosphate
23%
Prednisone
23%
Clinical Significance
23%
Sialyltransferase
23%
Interferon
23%
Epinephrine
22%
Vincristine
19%
Cyclophosphamide
19%
Diseases
19%
Platelet
19%
Peripheral Blood Mononuclear Cell
18%
Large-Cell Lymphoma
17%
Monocytosis
17%
Bone Marrow Cell
16%
Chemotherapy
16%
Immunoglobulin Producing Cell
16%
Liver Biopsy
15%
Myeloproliferative Disorder
14%
Hyperviscosity Syndrome
14%
Refractory Anemia
14%
Rituximab
13%
Thrombocyte Factor 3
13%
Prevalence
13%
Chronic Myelomonocytic Leukemia
12%
Arm
11%
Myeloma
11%
Programmed Cell Death
11%
Wilson's Disease
11%
Incubation
11%
Precursor
11%
Systematic Review
11%
Rare Disease
11%
Melphalan
11%
Pericarditis
11%
Blast Cell
11%
Splenectomy
11%
Interferon Alfa 2b
11%
AL Amyloidosis
11%
Essential Thrombocythaemia
11%